Clinical trials
Recruiting Phase 1/2 Primary Myelofibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| University of California, Irvine | 2 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| Disc Medicine, Inc | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 1 |
| Sumitomo Pharma America, Inc. | 1 |
| Telios Pharma, Inc. | 1 |
| iOnctura | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 11 |
| Anemia | 2 |
| Myeloproliferative Disorders | 2 |
| Leukemia, Myelomonocytic, Chronic | 1 |
| Myelodysplastic Syndromes | 1 |
| Polycythemia Vera | 1 |
| Thrombocythemia, Essential | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.